Maureen Martino

Articles by Maureen Martino

Argentina fines GSK $93K for Synflorix vaccine trial

Argentina's government has fined GlaxoSmithKline ($GSK) $93,000 for its management of trials of the vaccine Synflorix in which 14 babies died. This case brings to light questions as to how big...

Sanofi to relaunch Shan5 in 2013

Sanofi ($SNY) subsidiary Shantha Biotech plans to relaunch the company's pentavalent Shan5 vaccine in 2013. The vaccine was removed from the World Health Organization's prequalification list...

Agenus inks Oncophage cancer vaccine deal with Russian company

Cancer vaccine developer Agenus has inked a licensing, development and manufacturing technology transfer agreement with Russian drug company NewVac. Under the deal, NewVac gets to manufacture, market...

FierceVaccines celebrates the holidays

Another year is over, and FierceVaccines is taking some time off to relax and celebrate the upcoming holidays. The newsletter won't be published next week, but we'll return to our regular schedule on

Canadian researcher gets FDA approval for HIV vaccine trial

The FDA has granted University of Western Ontario researchers approval to start human trials of their HIV vaccine. Even though Dr. Chil-Yong Kang and his team trail others in their field who have...

Oxford researchers find malaria vaccine target

Scientists at the University of Oxford have identified a potential malaria vaccine that succeeded in neutralizing all strains of Plasmodium falciparum, the most deadly form of the disease, in...

Pfizer, GSK to provide more discount vaccines for GAVI

Pfizer ($PFE) and GlaxoSmithKline ($GSK) will provide the Global Alliance for Vaccines and Immunization (GAVI) with 360 million more pneumonia vaccines for the bargain price of $3.50 per dose....

GE jumps in to biologics, vaccine manufacturing game

GE Healthcare is gearing up to give established pharma companies competition in emerging markets. The company announced this week it's teaming with German engineering firm M+W Group to help...

Novartis opens doors to $1B vaccine plant

Federal officials have cleared Novartis' North Carolina-based vaccine plant for production of flu vaccines in the event of an influenza outbreak. The $1 billion plant is the first in the U.S. to...

Preclinical vaccine shrinks tumors 80%

Researchers at the Mayo Clinic and the University of Georgia have conducted preclinical trials of a vaccine that trains the body to recognize a protein called MUC1 that's present on 70% of...